<DOC>
	<DOCNO>NCT00842075</DOCNO>
	<brief_summary>The investigator hypothesize subcutaneous pramlintide adjunct mealtime insulin immediately prior meal significantly reduce post-prandial glucose concentration compare mealtime insulin alone child type 1 diabetes . This 36 day , randomize , two-arm , open-label study treatment arm ( take pramlintide meal ) control arm ( diabetes regimen usual ) .</brief_summary>
	<brief_title>Pramlintide Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description>Participants age 13-17 year diagnose type 1 diabetes 1 year invite participate.Other inclusion factor : - HbA1c level 7.5 10 % inclusive - Currently use carbohydrate insulin ratio - Acceptable form birth control Exclusion factor : - Oral hyperglycemic agent medication might affect blood sugar level - Recurrent severe hypoglycemia require assistance previous 6 month - Diagnosis gastroparesis and/or require use drug stimulate gastrointestinal motility - Previous use pramlintide The study consist 2 overnight stay CTRC continuous glucose monitoring system worn twenty-four hour . Blood drawn 15 minute prior start meal three hour follow meal . Meals control carbohydrate , fat protein content . Meals identical CTRC visit . After baseline visit participant , randomization occur either Treatment Control.Bolus insulin adjust participant begin pramlintide likely remain reduced rate throughout trial . All participant access staff assist insulin dose . There six mandatory phone visit 36 day ensure safety participant study . Insulin , glucose glucagon level assess well pramlintide level final visit study . Hypoglycemic event track , well adverse event .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pramlintide</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>Between 13 17 year age , inclusive Diagnosed type 1 diabetes &gt; 1 year Hemoglobin A1c 7.5 10 % inclusive Currently use carbohydrate insulin ratio Acceptable form birth control Use oral hyperglycemic agent medication affect blood sugar level Recurrent severe hypoglycemia require assistance past 6 month History hypoglycemia unawareness History gastroparesis require use drug stimulate gastrointestinal motility Previous use pramlintide</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>adolescent</keyword>
	<keyword>post prandial glucose</keyword>
</DOC>